Parkman Healthcare Partners’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,753,630
| Closed | -$7.37M | – | 108 |
|
|
2023
Q1 | $7.37M | Buy |
1,753,630
+344,988
| +24% | +$1.45M | 1.6% | 25 |
|
|
2022
Q4 | $8.47M | Buy |
1,408,642
+198,497
| +16% | +$1.19M | 2.25% | 12 |
|
|
2022
Q3 | $7.04M | Buy |
1,210,145
+159,098
| +15% | +$926K | 2% | 17 |
|
|
2022
Q2 | $6.28M | Buy |
1,051,047
+826,047
| +367% | +$4.93M | 2.31% | 16 |
|
|
2022
Q1 | $1.05M | Buy |
+225,000
| New | +$1.05M | 0.31% | 66 |
|